Drug retailers feel the heat as Amazon launches online pharmacy
Shares of drug retailers such as CVS Health Corp (NYSE: CVS) and Walgreens Boots Alliance Inc. (NASDAQ: WBA) fell in the mid-day trading Tuesday following the news.
avatar
Staff or Guest writer for The Dog of Wall Street.
2020-11-17 12:53

Amazon.com Inc. has launched an online pharmacy for selling prescription medicines across the U.S. Shares of drug retailers such as CVS Health Corp (NYSE: CVS) and Walgreens Boots Alliance Inc. (NASDAQ: WBA) fell in the mid-day trading Tuesday following the news.

Drug retailers feel the heat as Amazon launches online pharmacy

The new store, named Amazon Pharmacy, will allow customers to compare prices of the medicines on the app. They can choose between their copayment and a non-insurance option while checking out. Amazon will offer heavy discount to its prime members on the store.

The Seattle, Washington-based company has disrupted many industries along its tremendous growth journey. Amazon, which initially started its operations as an online bookseller, has been giving tough competition to companies in the retail and computing industries, and now the leading players in the pharmaceutical market will also face the heat after the latest announcement. The company has also faced criticism from labor groups and regulators in the past over its size and power.

The e-commerce giant’s new venture will now directly compete with Walgreens Boots, CVS Health, Walmart, Rite Aid, Kroger, and others. Online purchase of medicines has been relatively low as compared to physical store purchases. However, the pandemic may drive the online sales of drugs.

In case of Amazon, its prime members maybe more inclined to order drugs online through its newly opened store, as the company is offering up to 80 percent discount on generic and up to 40 percent discount on brand drugs when prime members decide to pay without insurance.

Amazon (NASDAQ: AMZN) shares slightly moved up in the mid-day trading Tuesday. If we look at the performance of the stock in the recent months, the stock has jumped more than 70 percent on year-to-date basis, about +31 percent over the past 6 months, and stayed nearly flat during the past 3 months.


Disclaimer: I have no positions in any of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article. All information should be independently verified and should not be relied upon for purposes of transacting securities or other investments. See terms for more info.

Rate this article

positive
negative
Published On
2020-11-17 12:53

avatar
About the Author
Staff or Guest writer for The Dog of Wall Street.


buy-coffee
You've read 1 article in the last year
..thank you for supporting us and for visiting our site. Unlike many other sites, The Dog of Wall Street is available for everyone to read. Our focus is to provide great content for free. Do you like what we are doing? Buy us a cup coffee. It is the fuel that keeps us going..

Levi Strauss' Bold Gambit: Is the Denim Icon's DTC Shift Enough to Weather the Storm?
Levi Strauss & Co. boasts a strong quarter with direct-to-consumer growth and innovative fashion, but can it navigate the choppy waters of the retail market?
By Alfonso | 10 months ago

Amazon's Bold Counterattack: Introducing the China-Direct Discount Section
As competition heats up, Amazon unveils a daring new strategy to offer unbeatable prices and direct shipping from China.
By Alfonso | 10 months ago

Tesla's Legal Challenges: Facing the Music on Autopilot Misrepresentation
Court ruling intensifies scrutiny on Tesla's self-driving claims.
By Alfonso | 11 months ago

Netflix's Ad-Supported Triumph: A New Era in Streaming
Surpassing 40 million users, Netflix’s ad-supported plan redefines the streaming landscape.
By Alfonso | 11 months ago

Tesla Stock (TSLA): Look Who's Back!
I’m cautiously optimistic but I’m at the point where I need to see it to believe it.
By Mike Sakuraba | 1 year ago

2 Earnings To Pay Attention to Next Week
Since big tech is the theme, you probably know what I have my eyes on for next week.
By Mike Sakuraba | 1 year ago

2 Stocks to Watch Below $10
Here are two stocks that are currently less trading in the single digits that I believe have some relative upside from their current prices.
By Mike Sakuraba | 1 year ago

Looking Ahead to Tesla's Earnings: What Can We Expect?
Is there any stock that has been more talked about than Tesla (NASDAQ: TSLA) as of late? It’s a company that is always in the spotlight but the stock is under some heavy scrutiny this year and deservedly so.
By Mike Sakuraba | 1 year ago